NCT04900532Completed
Effects of Supplementation With Tocotrienol on Chronic Kidney Disease Patients
Effects of Supplementation With Tocotrienol on Inflammation, Oxidative Stress and Microbiota of Chronic Kidney Disease Patients
Source: ClinicalTrials.gov · Last updated 26 Feb 2024
Brief summary (registry, in English)
The objective of this study is to evaluate the supplementation with tocotrienol, a vitamin E compound on inflammation, oxidative stress, and microbiota on Chronic Kidney Disease patients.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 61 (actual)
- First submitted
- 4 Dec 2020
- Start date
- 1 May 2019
- Primary completion date
- 1 Aug 2019
- Lead sponsor
- Universidade Federal Fluminense
- Diseases
- Chronic kidney disease
- NCT number
- NCT04900532
What you commit to
- Study type: Interventional
- Participants enrolled: 61
- From 1 May 2019 to the primary completion date, 1 Aug 2019
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Usual intake Autoimmune
Other
- Pregnant patients
- Smokers
- Using antibiotics in the last 3 months
- Using antioxidant supplements in the last 3 months
- Hemodialysis started less than 6 months for hemodialysis patients
Who the study is looking for
- Chronic kidney disease
- Aged from 18 to 60 years
- Must be able to swallow capsules
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Denise mafra Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Unknown status |
Related publications
- Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial.J Nutr Metab · 2025 · PMID 39840146
This page is information, not medical advice. Discuss any trial with your doctor.